AAL
53
3
PEP
41
-4
STZ
52
3
MAR
59
-6
ABBV
50
-7
SLG
39
9
QRVO
55
2
EQIX
59
5
EMR
70
2
HPE
57
5
DVA
49
2
TJX
65
4
AAPL
56
-5
ACN
50
-6
MSI
50
3
AA
72
2
PHM
57
-2
CCI
41
5
V
44
8
URI
40
-3
AAL
53
3
PEP
41
-4
STZ
52
3
MAR
59
-6
ABBV
50
-7
SLG
39
9
QRVO
55
2
EQIX
59
5
EMR
70
2
HPE
57
5
DVA
49
2
TJX
65
4
AAPL
56
-5
ACN
50
-6
MSI
50
3
AA
72
2
PHM
57
-2
CCI
41
5
V
44
8
URI
40
-3
Financhill
Back

Actuate Therapeutics, Inc. 10K Form

Buy
51

ACTU
Actuate Therapeutics, Inc.

Last Price:
$7.34
Seasonality Move:
-23.17%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ACTU News And Ratings

See the #1 stock for the next 7 days that we like better than ACTU

ACTU Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-6.5M
Price / Cash Flow: 0
Annual Sales: $0.47
Price / Book: 15.62

Profitability

EPS (TTM): -1.20950
Net Income (TTM): $-24.1M
Gross Margin: $0
Return on Equity: -1392.96%
Return on Assets: -228.64%

Actuate Therapeutics, Inc. Earnings Forecast

Key Actuate Therapeutics, Inc. Financial Ratios

  • Per Share Earnings over the last 3 years have been positive in 0 years.

Actuate Therapeutics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ACTU
Website: actuatetherapeutics.com

Debt

Debt-to-Equity Ratio: 0.04
Current Ratio: 2.74
Quick Ratio: 2.66

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ACTU Technical Analysis vs Fundamental Analysis

Buy
51
Actuate Therapeutics, Inc. (ACTU) is a Buy

Is Actuate Therapeutics, Inc. a Buy or a Sell?